Navigation Links
Office of Administration Announces Plan to Preserve Health Care Benefits for Current, Future Retired Commonwealth Employees
Date:9/28/2007

ducing cost increases that challenge fiscal stability of the program. In announcing these changes, we want to stress that coverage is not being eliminated for any retiree.

Retiree health care benefits have long been important to the Commonwealth. The Commonwealth of Pennsylvania began providing health care coverage to its retirees in 1963. When this coverage first was offered, the commonwealth paid just $4 million on an annual basis for the entire program. Even after the commonwealth began to offer paid benefits to its annuitants in 1977, the annual cost of the REHP still was only $68 million. Today, the commonwealth funds in excess of $550 million for the REHP benefit programs, which equates to approximately $9,250 per year per retiree.

Retiree health care coverage is an important benefit that unfortunately has become increasingly rare in America. The cost of these benefits has escalated dramatically in the past two decades. Such increases, among other factors, have caused many employers to eliminate these benefits, leaving retirees without coverage and/or entirely dependent on the Medicare system. The commonwealth remains committed today, as it has been for more than 40 years, to providing these benefits. In so doing, we also must consider the economic realities of the modern health care marketplace.

In just the last four years, the REHP costs have increased 63%. Looking ahead, we see little relief from these escalating costs. In fact, by fiscal year 2008/09, it is expected that the REHP costs will account for 18% of payroll, whereas just five years ago these costs were 9% of payroll. An added pressure point for the commonwealth takes effect this year in the form of a new government accounting standard that requires the commonwealth to account for the entire future cost of retiree health care benefits. We estimate this liability, absent cost containment measures, to be a staggering $14 billion, or nearly one-half of this year's General Fund.

<
'/>"/>
SOURCE Pennsylvania Office of Administration
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine news :

1. Sitting in office for long hours can cause overweight and obesity
2. Refreshing Assam Tea Now At The Nearest Post Office
3. Gigantic Effort: Smoking To Be Banned in British Telecom’s Offices and Van
4. Officer of Anti-Submarine Squadron Quarantined With Tuberculosis
5. Forearm Support for Office Desks Could Be a Boon
6. Normalcy Returns To AIIMS; Venugopal Attends Office
7. Women Prefer Office Procedure during treatment of Early Pregnancy
8. Smoking to be Prohibited at Public Offices in Bangkok from 2008
9. Researchers Developing Office-Based Cancer Screening Test
10. Health watch dog to scrutinize office cafeterias
11. Colorectal Cancer Getting Missed Out in Office Setting
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:Waismann Method Offers Safe and Alternative Treatment for Dependency to Ambien 2Waismann Method Offers Safe and Alternative Treatment for Dependency to Ambien 3Pivotal Trial Data Demonstrate NeuroPace RNS(R) System Reduced Seizures in People With Epilepsy 2Pivotal Trial Data Demonstrate NeuroPace RNS(R) System Reduced Seizures in People With Epilepsy 3Pivotal Trial Data Demonstrate NeuroPace RNS(R) System Reduced Seizures in People With Epilepsy 4ChemoCentryx Reports Additional New Data from the PROTECT-1 Study Demonstrating Traficet-EN's Effectiveness in Maintaining Remission in Patients with Crohn's Disease 2ChemoCentryx Reports Additional New Data from the PROTECT-1 Study Demonstrating Traficet-EN's Effectiveness in Maintaining Remission in Patients with Crohn's Disease 3ChemoCentryx Reports Additional New Data from the PROTECT-1 Study Demonstrating Traficet-EN's Effectiveness in Maintaining Remission in Patients with Crohn's Disease 4ChemoCentryx Reports Additional New Data from the PROTECT-1 Study Demonstrating Traficet-EN's Effectiveness in Maintaining Remission in Patients with Crohn's Disease 5ChemoCentryx Reports Additional New Data from the PROTECT-1 Study Demonstrating Traficet-EN's Effectiveness in Maintaining Remission in Patients with Crohn's Disease 6ChemoCentryx Reports Additional New Data from the PROTECT-1 Study Demonstrating Traficet-EN's Effectiveness in Maintaining Remission in Patients with Crohn's Disease 7Oakstone Medical Publishing Launches Unique Website Specifically Geared to Radiologists and Their Continuing Education Needs 58624 1Oakstone Medical Publishing Launches Unique Website Specifically Geared to Radiologists and Their Continuing Education Needs 58624 2OAKWORKS Clinician Massage Table Product Line Gets a Green Makeover 58621 1OAKWORKS Clinician Massage Table Product Line Gets a Green Makeover 58621 2OAKWORKS Clinician Massage Table Product Line Gets a Green Makeover 58621 3OAKWORKS Clinician Massage Table Product Line Gets a Green Makeover 58621 4OAKWORKS Clinician Massage Table Product Line Gets a Green Makeover 58621 5Ulcerative Colitis Treatment Reduces Need for Surgery by Almost Half 58618 1Ulcerative Colitis Treatment Reduces Need for Surgery by Almost Half 58618 2Ulcerative Colitis Treatment Reduces Need for Surgery by Almost Half 58618 3